Risks of Adverse Events in Treated Chronic Hepatitis C Patients with Cirrhosis Compared to without Cirrhosis in Real-World Settings

被引：0
|
作者：
Shen, Sophie W. [1 ]
Ives, Jennifer Wood [1 ]
Hines, Patricia [2 ]
Dimitrova, Dessislava [1 ]
机构：
[1] Bristol Myers Squibb Co, Global Pharmacovigilance & Epidemiol, Hopewell, NJ USA
[2] Bristol Myers Squibb Co, Ctr Observat Res & Data Sci, Hopewell, NJ USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2013年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
128
引用
收藏
页码：65 / 66
页数：2
相关论文
共 50 条
  • [31] Immunoprognostic Criteria of Cirrhosis in Chronic Hepatitis C Patients
    Balmasova, I. P.
    Yushchuk, N. D.
    Malova, E. S.
    Shineleva, E., V
    Eremina, O. F.
    Zaitseva, M. N.
    Dunda, N., I
    WORLD ALLERGY CONGRESS (WAC), 2009, : 99 - +
  • [32] Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study
    Fanpu Ji
    Wenjun Wang
    Shuangsuo Dang
    Shengbang Wang
    Burong Li
    Dan Bai
    Wenxue Zhao
    Hong Deng
    Changyin Tian
    Zongfang Li
    Infectious Agents and Cancer, 12
  • [33] Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study
    Tahata, Yuki
    Hikita, Hayato
    Mochida, Satoshi
    Kawada, Norifumi
    Enomoto, Nobuyuki
    Ido, Akio
    Yoshiji, Hitoshi
    Miki, Daiki
    Hiasa, Yoichi
    Takikawa, Yasuhiro
    Sakamori, Ryotaro
    Kurosaki, Masayuki
    Yatsuhashi, Hiroshi
    Tateishi, Ryosuke
    Ueno, Yoshiyuki
    Itoh, Yoshito
    Yamashita, Taro
    Kanto, Tatsuya
    Suda, Goki
    Nakamoto, Yasunari
    Kato, Naoya
    Asahina, Yasuhiro
    Matsuura, Kentaro
    Terai, Shuji
    Nakao, Kazuhiko
    Shimizu, Masahito
    Takami, Taro
    Akuta, Norio
    Yamada, Ryoko
    Kodama, Takahiro
    Tatsumi, Tomohide
    Yamada, Tomomi
    Takehara, Tetsuo
    JOURNAL OF GASTROENTEROLOGY, 2021, 56 (01) : 67 - 77
  • [34] Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study
    Ji, Fanpu
    Wang, Wenjun
    Dang, Shuangsuo
    Wang, Shengbang
    Li, Burong
    Bai, Dan
    Zhao, Wenxue
    Deng, Hong
    Tian, Changyin
    Li, Zongfang
    INFECTIOUS AGENTS AND CANCER, 2017, 12
  • [35] Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort)
    Hsu, Wei-Fan
    Tsai, Pei-Chein
    Chen, Chi-Yi
    Tseng, Kuo-Chih
    Lai, Hsueh-Chou
    Kuo, Hsing-Tao
    Hung, Chao-Hung
    Tung, Shui-Yi
    Wang, Jing-Houng
    Chen, Jyh-Jou
    Lee, Pei-Lun
    Chien, Ron-Nan
    Lin, Chun-Yen
    Yang, Chi-Chieh
    Lo, Gin-Ho
    Tai, Chi-Ming
    Lin, Chih-Wen
    Kao, Jia-Horng
    Liu, Chun-Jen
    Liu, Chen-Hua
    Yan, Sheng-Lei
    Bair, Ming-Jong
    Su, Wei-Wen
    Chu, Cheng-Hsin
    Chen, Chih-Jen
    Lo, Ching-Chu
    Cheng, Pin-Nan
    Chiu, Yen-Cheng
    Wang, Chia-Chi
    Cheng, Jin-Shiung
    Tsai, Wei-Lun
    Lin, Han-Chieh
    Huang, Yi-Hsiang
    Huang, Jee-Fu
    Dai, Chia-Yen
    Chuang, Wan-Long
    Yu, Ming-Lung
    Peng, Cheng-Yuan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (10) : 2884 - 2892
  • [36] Real-world efficacy of sofosbuvir plus velpatasvir therapy for patients with hepatitis C virus-related decompensated cirrhosis
    Ohya, Kazuki
    Imamura, Michio
    Teraoka, Yuji
    Morio, Kei
    Fujino, Hatsue
    Nakahara, Takashi
    Ono, Atsushi
    Murakami, Eisuke
    Kawaoka, Tomokazu
    Miki, Daiki
    Tsuge, Masataka
    Hiramatsu, Akira
    Aikata, Hiroshi
    Hayes, C. Nelson
    Mori, Nami
    Takaki, Shintaro
    Tsuji, Keiji
    Aisaka, Yasuyuki
    Ishitobi, Tomokazu
    Katamura, Yoshio
    Kodama, Hideaki
    Nabeshima, Yoshitaka
    Masaki, Keiichi
    Honda, Yohji
    Moriya, Takashi
    Kohno, Hirotaka
    Kohno, Hiroshi
    Chayama, Kazuaki
    HEPATOLOGY RESEARCH, 2020, 50 (11) : 1234 - 1243
  • [37] Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study
    Yuki Tahata
    Hayato Hikita
    Satoshi Mochida
    Norifumi Kawada
    Nobuyuki Enomoto
    Akio Ido
    Hitoshi Yoshiji
    Daiki Miki
    Yoichi Hiasa
    Yasuhiro Takikawa
    Ryotaro Sakamori
    Masayuki Kurosaki
    Hiroshi Yatsuhashi
    Ryosuke Tateishi
    Yoshiyuki Ueno
    Yoshito Itoh
    Taro Yamashita
    Tatsuya Kanto
    Goki Suda
    Yasunari Nakamoto
    Naoya Kato
    Yasuhiro Asahina
    Kentaro Matsuura
    Shuji Terai
    Kazuhiko Nakao
    Masahito Shimizu
    Taro Takami
    Norio Akuta
    Ryoko Yamada
    Takahiro Kodama
    Tomohide Tatsumi
    Tomomi Yamada
    Tetsuo Takehara
    Journal of Gastroenterology, 2021, 56 : 67 - 77
  • [38] Recombinant interferon alpha therapy in elderly patients with chronic hepatitis C without cirrhosis
    Russello, M
    Vasquez, E
    Fraggetta, F
    Zammataro, M
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 1996, : 321 - 325
  • [39] Neuropsychological impairment in a cohort of Nigerian patients with chronic hepatitis C without liver cirrhosis
    Salawu, F.
    Wakil, A.
    Pindar, S.
    Beida, O.
    Danburam, A.
    Martins, T.
    Agbo, J.
    JOURNAL OF NEUROLOGY, 2007, 254 : 171 - 172
  • [40] Adverse Events in Patients with Chronic Hepatitis C
    Shen, Sophie W.
    Dimitrova, Dessislava
    Wu, Jasmanda
    Hines, Patricia
    Gomez-Caminero, Andres
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S191 - S192
12345